Navigation Links
Hot topics in translational bone research at IOF-ESCEO 3rd Pre-Clinical Symposium
Date:1/25/2013

Investigators with an interest in pre-clinical and translational musculoskeletal research are invited to attend the 3rd IOF-ESCEO Pre-Clinical Symposium to be held on April 18, in Rome, Italy.

The Symposium will be held in conjunction with the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) from April 17-20, 2013. This key clinical bone event is held annually by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), http://www.ecceo13-iof.org

The Congress will present more than 700 scientific abstracts and is expected to attract over 5000 delegates from around the world.

Chaired by Anna Teti, Professor of Histology at the University of L'Aquila, L'Aquila, Italy, the half-day IOF-ESCEO Pre-Clinical Symposium features eight invited lectures by well-known researchers in the field:

How do rare genetic diseases contribute to the understanding of common bone diseases?

  • The contribution of chondrodysplasias to the understanding of osteoarthritis - Michael Briggs
  • The contribution of osteodysplasias to the understanding of osteoporosis - Wim van Hul

How do preclinical studies offer new options for future developments?

  • Future molecular therapies for osteoporosis - Lorenz C Hofbauer
  • New potential developments using siRNA and small peptides - Anna Teti

How does the skeleton impact muscle cells?

  • Vascular calcification - Catherine Shanahan
  • Key regulators of muscle-bone unit - Roger Fielding

How does the skeleton contribute to ion metabolism?

  • Anion transport mechanisms and diseases - Thomas J Jentsch
  • Cation transport mechanisms and diseases - H. van Leeuwen

The 3rd Pre-Clinical Symposium is free of charge to registrants of ESCEO13-IOF, while delegates to the Symposium alone may register for only 150 Euro. With the low registration rate, IOF and ESCEO specifically aim to make the Symposium accessible to young investigators in the field.


'/>"/>
Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. Topics to be discussed during July International Coral Reef Symposium
2. Elsevier launches new open access journal: Applied and Translational Genomics
3. Autism Speaks and SAGE® Labs develop rat models for translational autism research
4. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
5. Research reveals first evidence of hunting by prehistoric Ohioans
6. Diabetes Research Institute develops oxygen-generating biomaterial
7. APS issues new policy requiring identification of sex or gender in reporting scientific research
8. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
9. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
10. U of Alberta researcher steps closer to understand autoimmune diseases
11. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ), a ... live webcast of its Annual Meeting of Shareholders on Tuesday, January ... can be accessed from the BD corporate website at http://www.bd.com/investors/ ... ... BD is a global medical technology company that is ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Clinical Ops Executives 2017 in its continued commitment to the advancement of the ... to discuss current issues related to clinical trial planning and management. , ...
Breaking Biology Technology: